US FDA explains how it deals with "requests for information" on device classification
This article was originally published in Clinica
Executive Summary
The US FDA has issued two guidelines explaining the agency's procedures for dealing with requests from device companies seeking information on the risk classification level of their products and the user fee associated with such applications.